According to the The European Academy of Allergy and Clinical Immunology, EAACI, by 2025, asthma will represent the most prevalent chronic childhood disease and result in one of the highest causes of health care costs (EAACI, 2014).
In a recent article by Jochen Schmitt, MD, MPH, of the Center for Evidence-based Healthcare at Medical Faculty Carl Gustav Carus in Germany, he summarised the results of research carried out on patients with allergic rhinitis who underwent allergy immunotherapy.
“Allergy immunotherapy effectively prevents the progression of allergic rhinitis to asthma”. Colleagues added “By reducing the risk for asthma, significant health care costs can be saved.”
We use three different immunotherapy methods in our clinics. S.L.I.T is a safe from of desensitisation we use for inhalant allergies, such as hay fever. It is given as self-administered drops, as opposed to the injections used in other conventional methods of immunotherapy.
Each method has it’s advantages which would be discussed at consultation.